Healthcare · Healthcare Services
The largest companies in the same industry by market cap. This company ranks #37 of 62. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.
| Company | Market cap (₹ Cr) | PE (TTM) | ROE | 1Y return | Div. yield | Quality | Valuation | Momentum |
|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | 114,812 | 73.1 | 20.1% | 4.2% | — | 73 | 0 | 27 |
| Max Healthcare Institute Limited | 89,246 | 124.3 | 13.4% | -19.5% | 0.22% | 77 | 0 | 26 |
| Fortis Healthcare Limited | 57,664 | 255.5 | 10.5% | -27.5% | 0.13% | 49 | 26 | 6 |
| Global Health Limited | 35,830 | 74.4 | 13.9% | -2.5% | 0.04% | 74 | 0 | 30 |
| Aster DM Quality Care Limited | 35,828 | 205.8 | 8.8% | 2.8% | 0.43% | 53 | 0 | 26 |
| Narayana Hrudayalaya Ltd. | 35,199 | 61.9 | 17.8% | -3.7% | 0.26% | 66 | 0 | 29 |
| Dr. Lal Path Labs Ltd. | 33,046 | 38.4 | 20.1% | -38.0% | 0.99% | 82 | 0 | 88 |
| Krishna Institute of Medical Sciences Limited | 29,629 | 105.1 | 9.5% | -2.3% | — | 47 | 0 | 29 |
| ASARFI HOSPITAL LIMITED (this stock) | 366 | — | — | 86.0% | — | 51 | — | 50 |
Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet. EBITDA = PBT + interest + depreciation.
| Period end | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) | Basic EPS |
|---|---|---|---|---|
| March 31, 2024 | 44 | 3 | 2 | ₹0.6000 |
| Indicator | Mar 24 |
|---|---|
| Total income (before exceptional items) | 45 |
| Operating revenue | 44 |
| Other income | 1 |
| Operating expenses | 36 |
| Operating profit | 8 |
| Operating profit margin | 18.1% |
| Depreciation | 4 |
| Interest | 1 |
| Exceptional items, gain / (loss) | — |
| Profit before tax | 3 |
| Tax | 1 |
| Net profit | 2 |
| EPS | 0.60 |
| Net profit (TTM) | — |
| EPS (TTM) | — |
Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.
Data unavailable (annual figures are only available from the NSE iXBRL feed's coverage period).
Data unavailable.
| Year ended | Operating (₹ Cr) | Investing (₹ Cr) | Financing (₹ Cr) | Capex (₹ Cr) | Free Cash Flow (₹ Cr) |
|---|---|---|---|---|---|
| March 31, 2026 | 18 | -18 | 5 | 18 | 0 |
| March 31, 2025 | -4 | -8 | 13 | 12 | -15 |
| Year ended | Total Assets (₹ Cr) | Total Equity (₹ Cr) | Reserves (₹ Cr) | Borrowings, Current (₹ Cr) | Borrowings, Non-current (₹ Cr) | Current Assets (₹ Cr) | Current Liabilities (₹ Cr) | Cash & Equivalents (₹ Cr) | Net Block (₹ Cr) | Inventory (₹ Cr) |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | 194 | — | — | — | — | 71 | 49 | 6 | 108 | 3 |
| March 31, 2025 | 164 | — | — | — | — | 58 | 41 | 1 | 101 | 2 |
